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ABSTRACT
This review aimed to explore recent published literature, research and practice in managing breast cancer wounds with a specific focus on the potential 
values of honey in managing the wounds. About 10 databases were searched (CINAHL, EBSCOhost, ProQuest, Google Scholar, Wiley Interscience, 
Science Direct, Blackwell Synergy, Liebert Online, Internurse, and Gale Cengage) using the search terms “fungating wound” OR “malignant wound,” 
“breast cancer wounds” AND “honey” AND “Indonesia.” The search was limited from period of 2006 to 2016, to English and Indonesian language, and 
only full text articles were included in the study. Reference lists of relevant articles were also hand searched. The search identified 12 articles that met 
the search criteria. An article published before 2006 was also included on the basis of its relevance. All articles were written in English. Publications 
have indicated that a malignant wound represents a cluster of symptoms such as malodor, heavy exudate, pain, bleeding, and various psychosocial 
issues. To stabilize and prevent wound deterioration, the physical and bioactive properties of honey may have potentials to be applied as a single 
treatment in primary wound dressings to manage offensive odor and heavy exudate. Further research to study native Indonesian honeys’ properties 
will be beneficial to assist with practice decisions.
Keywords: Breast cancer, Fungating wounds, Honey, Wound management.
INTRODUCTION
In a nearly three-decade period (1990-2014), there was a shift in the 
global distribution of breast cancer cases. While incidence rates still 
remained much higher in more developed countries, breast cancer 
was found to become a major health issue for women in Asia, Africa, 
and South America. During 2012, nearly a quarter of all breast cancer 
cases were diagnosed within the Asia-Pacific region, home of a third of 
global female population (at a rate of 30 per 100, 000), with the highest 
number of those occurring in China (46%), Japan (14%), and Indonesia 
(12%) [1]. In Asia, breast cancer tends to occur at a younger age (more 
than 50% of the patients are under 50-year-old) notwithstanding 
various levels of income of its countries [2]. In a low- and middle-income 
Asian country like Indonesia, about 60% of cancer patients seek for 
medical care when the disease is already in an advanced stage [2,3].
It is mainly believed that people living with advanced or terminal-stage 
chronic illnesses such as cancers may develop chronic wounds even with 
the best nursing practice [4]. Such lesions are frequently identified as 
malignant wounds that commonly have occurrence in advanced cancer 
patients, when there are indications of infiltration and erosion through 
the skin by malignant tumor cells. Besides, phenotypic changes of resident 
cells characterize these chronic or delayed-healing wounds [5,6].
There are some terms that have usually been used to illustrate these 
wounds, for example, “fungating malignant wounds,” “ulcerating 
malignant wounds,” or “malignant cutaneous wounds.” In addition, 
the term “fungating wound” mostly refers to a lesion that primarily 
possesses a proliferative growth pattern, thus creates a nodular 
“fungus-shaped” or “cauliflower-shaped” lesion development. 
Conversely, the term “ulcerating wound” generates an appearance of a 
crater-like lesion. However, a mixed appearance of both proliferating 
and ulcerating areas may be shown in a lesion which is often confusing 
for nurses, so they most likely correlate the term “fungating wound” 
with breast cancer solely [6]. A study found that about 62% of malignant 
wounds developed within the breast area, even though they were not 
primarily originated from breast tissue [7]. Particularly, up to 25% of 
patients with breast cancer suffer from skin metastasis [8].
Women with advanced breast cancer are prone to having a greater risk 
of psychological morbidity and a wide-range of physical symptoms [9]. 
It is predicted that between 2% and 5% of breast cancer patients will 
develop a malignant wound which is an overwhelming complication 
that usually indicates progressive and untreatable disease with limited 
therapeutic options and an ominous prognosis [2,10]. This complexity 
is challenging for health practitioners, especially nurses in providing 
care across the cancer continuum [11,12].
A recent qualitative study in Indonesia revealed that most of the 
breast cancer patients (N=17) initially opted for traditional health 
treatments and alternative therapies. If the initial choices were not 
effective, the patients would likely try the conventional therapy. Finally, 
the patients might have the conventional therapy in conjunction 
with complementary and traditional therapies [13]. The reliance on 
traditional healing methods may be attributable to limited access to, 
and high cost of, medical service, or to cultural beliefs and mistrust 
toward the health-care services [8]. Conversely, the majority of health 
professionals (N=12) supported conventional therapy as a single 
treatment. However, the health professionals expected that in the 
future there would be an effective therapy for breast cancer patients 
with less adverse effects combining conventional and complementary 
therapies [13].
Derived from the goals of palliative care, the essential goal of palliative 
wound care is to prioritize patient comfort by symptoms control and 
giving psychosocial support [14]. Accordingly, in low resource countries, 
while formal research into the efficacy of many traditional remedies is 
inadequate, local natural resources are frequently utilized in wound 
management on account of limited or unaffordable access to modern 
wound care products [15]. One of popular natural products used in the 
treatment of wounds since thousand years ago is honey. In the past few 
decades, there has been considerable resurgence of interest in the use 
of honey in wound management [11,16]. The purpose of this review is 
to explore recent literature, research and practice in managing breast 
cancer wounds with a specific focus on the potential values of honey in 
managing the wounds.
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To explore publications providing information regarding current 
literature, research, and practice in managing malignant wounds for 
breast cancer patients, a search was conducted through 10 databases 
(CINAHL, EBSCOhost, ProQuest, Google Scholar, Wiley Interscience, 
Science Direct, Blackwell Synergy, Liebert Online, Internurse, and Gale 
Cengage) using the search terms “fungating wound” OR “malignant 
wound,” “breast cancer wounds” AND “honey” AND “Indonesia.” 
The search was limited from period of 2006 to 2016, to English and 
Indonesian language, and only full text articles were included in the 
study.
By using the above initial criteria, 15 full text articles were found to 
have potential in providing information related to malignant wound 
management in the breast cancer patients. All articles were written in 
English; none were in Indonesian. Afterward, 7 articles were chosen 
and 8 articles were not included because they were not relevant with 
the search aim. Subsequently, the reference lists from those 7 articles 
were hand searched and resulted in one potential full text article 
published before 2006 to be included in this review on the basis of its 
relevance with the search aim.
RESULTS AND DISCUSSION
Following the search strategies, 12 articles were selected. These articles 
were written by various professionals, including nurses, oncologists, 
physicians, and biochemist from different parts of the world 
(Australia [17-19], Brazil [20], Denmark [21,22], New Zealand [23-25], 
Taiwan [26], Turkey [27], and United Kingdom [28]). Three articles are 
elements of a series to summarize the literature on malignant wounds 
in a holistic configuration to assist with practice decisions [17-19]. Two 
articles lay emphasis on exploring patients’ experiences of living with 
malignant wounds [21,26]. Five articles synthesize evidence of honey 
as topical treatments for wounds [23-25,27,28]. One article focuses 
on topical treatments for controlling odor in malignant wounds [20]. 
Of all 12 articles, only one specifically studied a particular group with 
breast cancer [21]. A global summary of the search results is presented 
in Table 1.
The information extracted from the review process reflects that the 
likelihood of malignant wound development in the breast cancer 
patients provides a multitude of opportunity for research and practice 
advancement in breast cancer wound management suitable with local 
Indonesian culture. The details are discussed below.
Development of malignant wounds
Malignant wounds in the most cases are developed through several 
mechanisms: (a) Metastatic growth of tumor cells from primary 
tumors, either local or distant, (b) primary cutaneous tumors, and 
(c) direct invasion by a primary tumor into skin structures [17,26]. In 
addition, malignant wounds have the ability to develop progressively 
and often enlarge within 24 hrs which can cause massive cutaneous 
destruction and create ulcerating or proliferating (“fungating”) 
appearance [17,20,26]. Moreover, even though every malignant 
tumor can metastasize to any region of the body, particular types of 
malignancies have a predilection for specific body sites. In women, for 
example, breast tumors commonly metastasize to the breast or chest 
wall [17].
Key symptoms in malignant wounds
Malignant wounds exemplify a range of symptoms that may present 
individually or collectively [20]. The major symptoms in malignant 
wounds discussed by most authors are as follows:
Malodor
Pungent odor results from the metabolic process of bacteria 
cultivating in the necrotic tissue (particularly anaerobic bacteria such 
as Bacteroides and Clostridium species) that release volatile putrid 
fatty acids which furthermore combine with metabolic products of 
other proteolytic bacteria [18,20,22]. Gas chromatography-mass 
spectrometry-olfactometry analysis of volatiles from fungating cancer 
wounds in a Japanese study resulted in the identification of dimethyl 
trisulfide as the source of malodor. Therefore, controlling the production 
of this compound could reduce the putrid smell from the wounds [30]. 
Malodor may also result from infection, hence systemic antibiotics are 
often administered [10].
Nurses often recognize malodor as one of the most difficult symptoms 
to control and the most distressing symptoms for patients, their 
careers, and families [18,26]. Especially in women, offensive odor 
decreases their sense of femininity, sexuality, and social intimacy as 
well as their body image and self-confidence [21,26]. Furthermore, 
malodor can be nauseating for both patients and family, thus reducing 
their appetite [31].
Exudate
Excessive exudate production in malignant wounds can arise from 
interrelated factors, including: (a) Fluid leakage from disordered 
and highly permeable tumor vasculature, (b) secretion of vascular 
permeability agents by tumor cells, (c) tissue catabolism by bacterial 
protease, and (d) Inflammatory processes associated with infection. 
In addition, exudates from chronic, non-healing wounds contain fewer 
growth factors, an increased level of proteolytic enzymes (matrix 
metalloprotease), and other corrosive substances that have potential 
to degrade the periwound tissue and expand the wound size [18]. 
Together with malodor, large quantities of exudate can lead to distress, 
social isolation and other psychosocial issues [18,20,26].
Pain
A number of factors causing physical pain sensation in malignant 
wounds, including: Pressure from the tumor mass on other body 
structures, damage to nerves by the progressing tumors, exposure of 
dermal nerve endings, recurrent infections, swelling resulting from 
impaired capillary and lymphatic drainage, and wound care procedures. 
In addition to pain, pruritus may also need the same attention as pain 
because it can cause discomfort as this sensation utilizes similar 
conduction pathway with pain [18].
Bleeding
Bleeding and clotting irregularities in malignant wounds often occur due 
to abnormal vasculature in progressing tumors. Alteration in peritumor 
angiogenesis and coagulopathy may result in excess of circuitous; 
thin-walled vessels that are vulnerable to bleeding and resistant to 
hemostasis. Moreover, the delicateness of a malignant wound may 
be exacerbated in advance by systemic coagulopathy yielding from 
existing comorbidities or therapeutic regimens. Consequently, possible 
erosion of major blood vessels should be treated cautiously [18].
Psychosocial issues
Potential psychosocial issues associated with malignant wounds 
identified from literature are as follows: Social isolation, alteration in 
body image, stigma, existential issues related to imminent death and 
the search for meaning in life, and alteration in relationships and loss 
of personhood. Where malignant wounds are located in greatly visible 
(head and neck) or intimate (breast or perineum) body sites, these 
issues are prone to be multifaceted [18]. Interconnection between 
psychosocial issues and other key physical symptoms, predominantly 
offensive odor and heavy exudates were also discussed [18,20,21,26].
THE POTENTIALS OF HONEY IN MANAGING BREAST CANCER 
WOUNDS
In general, the most articles reveal conventional modern dressings 
and several topical treatment products that have been widely 
applied in managing malignant wounds. For example, systemic and 
topical metronidazole, silver dressing, and activated charcoal have 




Author(s) Country  
(language)
Aim Method Findings Significance to 
malignant wounds 
management in breast 
cancer patients




on the epidemiology, 
etiology, presentation, 
and assessment of 
malignant wounds 
to inform practice 
decisions
Literature review Undefined incidence rate of 
malignant wounds
Breast tumors have metastasis 
predilections to breast or chest 
wall
Focus of assessment should 
incorporate all domains of the 
patient’s experience of illness
Provides a 
comprehensive guideline 
for malignant wound 
assessment in breast 
cancer patients
[18] Australia  
(English)
To summarize 
existing literature on 
the key symptoms of 
malignant wounds 
to inform practice 
decisions
Literature review Key symptoms include physical 
symptoms (malodor, exudates, 
pain, and bleeding) and 
psychosocial symptoms
Malodor was the most 
distressing symptom and 
the most difficult to manage. 
Heavy exudates, pain, and 





issues related to 
malignant wounds in 
breast cancer patients
[19] Australia  
(English)
To summarize 
existing literature on 
the management of 
malignant wounds 
to inform practice 
decisions
Literature review Healing of malignant wounds 
is not a realistic goal
Management of malignant 
wounds best provided through 
a multidisciplinary approach
Inter-relatedness of physical 
and psychological domains
The key of successful 
management of malignant 
wounds is comprehensive 
and individualized 
assessment
Needs further research 
in management of 
malignant wounds in 
breast cancer patients 
as most of available 
literature is based on 
general chronic wounds
Less robust designs 
such as multiple case 
studies may provide the 
highest level evidence 
because undertaking 
RCTs on individuals with 
unstable condition such 
as malignant wounds 
is difficult, especially in 
controlling variables
[20] Brazil  
(English)
To collect evidence 
about topical 
treatments to control 
the odor of malignant 
wounds
Systematic review 20 studies were reviewed, 
7 were clinical trials, 5 were 
case series, and 8 were case 
studies
11 topical treatments were 
identified, three topical 
treatments (Mesalt®, activated 
carbon and curcumin) were 
categorized as moderate 
evidence
Needs development 
for innovations in 
managements of 
malignant wounds in 
developing countries 
as Mesalt® dressing is 
not available in many 
countries, activated 
carbon dressings are 
still expensive, and 
curcumin ointment is a 
new practice that is not 
available commercially
[21] Denmark  
(English)




sexuality, and daily 
life in women with 
progressive breast 
cancer
Exploratory study Malodorous and heavy exuding 
wounds trigger anxiety about 
leakage, make women avoid 
wearing feminine attire and 
moving toward physical 
intimacy and sexual activity
The use of modern wound 
care products improved the 
experience of comfort and 
sense of and freedom
Needs for standardized 
methods of practice 
for care of malignant 
wounds in women with 
breast cancer





Author(s) Country  
(language)
Aim Method Findings Significance to 
malignant wounds 
management in breast 
cancer patients
[22] Denmark  
(English)








clinical study (N=67: 
Group A - Manuka 
honey dressing; 
N=34: Group B - Silver 
dressing; N=33: Over a 
4-week period)
The majority of the patients 
were women with breast 
cancer
Almost all wounds contained 
at least one type of pathogen
The qualitative 
bacteriological did not differ 
over time or between the two 
dressings
Swab cultures of 
malignant wounds 
should not be routinely 
performed and the 
potential antibacterial 
effect of the dressings 
used could not be 
confirmed in this patient 
population





Review Findings from 17 RCTs, 
5 clinical trials, large amount 
of case studies, and 16 trials on 
experimental animals showed 
that honey give good results 
on a very wide range of types 
of wounds
Laboratory studies found 
that honey stimulates 
cytokines production 





has potential benefits in 
malignant wound care 
due to its bioactivities
[24] New Zealand 
(English)
To determine the use 
of honey in increasing 
the rate of healing 
in various acute and 
chronic wounds
Review 19 trials (randomized and 
quasi randomized) were 
reviewed
Honey may improve healing 
times in mild and moderate 
superficial and partial 
thickness burns compared 
with some conventional 
dressings
Honey dressings as adjuvant 
to compression do not 
significantly increase healing 
in leg ulcers
There was insufficient 
evidence to guide clinical 




determine the benefit of 
honey in breast cancer 
wounds
[25] New Zealand 
(English)
To describe honey 
as a biologic wound 
dressing
Review Honey has a broad-spectrum 
antibacterial activity, but there 
is much variation in potency 
between different honeys
There is good evidence 
showing that honey also 
possesses bioactivities 
that stimulate the immune 
response (thus promoting 
the growth of tissues for 
wound repair), suppress 
inflammation, and bring 
about rapid autolytic 
debridement
Each of the 
healing-promoting activities 
can be found separately 
in most pharmaceutical 
products, but in honey they 
are all present and work 
together synergistically to 
enhance the wound healing 
process
Needs further study 
on the bioactive and 
physical properties of 
local Indonesian honeys, 







and silicone dressings have been used to manage exudates; topical 
analgesia for managing pain; and hemostatic alginates for treating 
bleeding [19-22,26]. Two recent emerging treatments have also 
been reported to be effective (Miltefosine―a topical cytostatic; and 
electrochemotherapy). However, many modern dressing products 
are expensive, so not all patients can afford the cost, especially if they 
live in countries with cost containment issues in health care. Thus, 
providing alternative options that are acceptable to the patients’ 
requirements is important [19].
Many alternative methods for managing malignant wounds were 
discussed in literature with very few of those supported by robust 
evidence [15,19,20]. One of the alternative methods that have been 
attracting interest to be used as wound dressing is honey [11,23,25].
Evidently, a large number of publications on laboratory studies 
showing that honey has a number of properties (physical and 
bioactive) that are beneficial in managing various wounds, including: 
Acidic (pH ranging from 3.2 to 4.5, can inhibit bacterial growth); high 
sugar content (osmotic effect, can draw exudate); contains an enzyme 
(glucose-oxidase, stimulates release of hydrogen-peroxide to function 
as antibacterial agent); stimulates release of cytokines and interleukins 
to promote tissue repair; and some types of honey (particularly 
Leptospermum/Manuka honey) have phytochemical components 
that maintain antibacterial activity [23-25,27,28]. Clinical trials have 
also shown that honey is a good alternative to surgical debridement 
possibly owing to its ability to increase plasmin activity; an enzyme that 
specifically digests fibrin (fibrin attaches slough to the wound surface) 
but does not digest the collagen matrix needed for tissue repair [25]. 
Moreover, a study reported that the use of honey as a single treatment 
had rapid cleansing and deodorizing action within 24 hrs, particularly 
on fungating (malignant) wounds. It also reduced inflammation and 
exudate levels [23]. Nonetheless, the potential of honey in treating pain 
and bleeding in malignant wounds was not extensively discussed in the 
reviewed articles.
IMPLICATIONS FOR PRACTICE, FURTHER RESEARCH AND POLICY
Multidisciplinary team approach is the paramount strategy in managing 
care for malignant wounds as the intricate nature of malignant wounds 
demands a realistic goal. Therefore, practices in malignant wound 
management will differ from those utilized in other settings, which 
aim toward healing [19,26]. It is also vital to perform an ongoing and 
comprehensive assessment which incorporates all domains of the 
patient’s illness experience as an essential key aspect in managing 
malignant wound effectively [17,18].
Author(s) Country  
(language)
Aim Method Findings Significance to 
malignant wounds 
management in breast 
cancer patients
[26] Taiwan  
(English)
To explore the 
experience of cancer 
patients living with 
malignant fungating 
wounds
Exploratory study Five key themes were 
identified: “Declining physical 
well-being”; “wound related 
stigma”; “need for expert 
help”; “strategies in wound 
management”; and “living 
positively with the wound”
Participants were able to live 
more positively with their 
wounds after receiving wound 
care advice, appropriate 
dressings, and support for 
self-care
Helps to guide nursing 
practice by giving 
understanding the 
meaning of a malignant 
wound to cancer patients 
and its influence to their 
lives
[27] Turkey  
(English)
To evaluate the 
effects of three types 
of honey (chestnut, 
blossom, and 
rhododendron) 
on the healing of 
full-thickness wounds
Experimental (involving 
24 New Zealand female 
rabbits)
A week after the wounds 
were created, the formation 
of granulation tissue, 
epithelization, angiogenesis 
and fibroplasia levels 
increased in the honey-treated 
groups (p<0.05)
No statistical difference 
between the three types of 
honey in the healing process
Honey accelerates the 
inflammatory reaction 
and initiates healing 
since the initiation of 
the treatment process 
of acute wounds. The 
benefits of honey for 
treating malignant 
wounds, especially in 
breast cancer patients 






honey’s role in health 
care and identify 
further specific 
application of honey 
in cancer care
Systematic review 43 studies were reviewed, only 
5 studies related to cancer
Studies were generally 
poor in quality because of 
small sample size, lack of 
randomization, and absence of 
blinding
Honey was found to be 
a suitable alternative for 
treating xerostomia, mucositis, 
malignant ulcers and infected 
lesions in pediatric cancer 
patients
In the oncology setting, 
honey may be useful 
for treating fungating 
wounds and surgical 
wounds following the 
removal of tumors





Some articles point out that managing physical symptoms will alleviate 
psychosocial symptoms, such as altered body image and social isolation, 
especially with women with malignant breast wounds [19,21,26]. In 
addition, treating the malignancies (e.g., chemotherapy, radiotherapy, 
hormone therapy, laser therapy, cryotherapy, and/or surgery) was 
reported to have significant support besides wound care [19]. Besides 
treating the underlying pathology, addressing nutrition and other 
supportive aspects of care should never be overlooked [32]. Policy 
needs to address the resource allocations to ensure the provision of 
the supportive care during treatment for breast cancer, especially 
for a low- and middle-income country like Indonesia [33]. Calvary 
Hospital, New York introduced an approach to palliative wound care 
in an inpatient, home, and outpatient setting: S - Stabilizing the wound; 
P - Preventing new wounds; E - Eliminate odor; C - Control pain; 
I - Infection prophylaxis; A - Advanced, absorbent wound dressing; 
L - Lessen dressing changes (SPECIAL) [32].
It is difficult to obtain robust evidence through randomized-
controlled trials in malignant wounds because reaching control in the 
circumstances of unstable or terminal disease is almost unfeasible. 
Less strong evidence from existing multiple case study designs 
should be acceptable for guiding practice in managing malignant 
wounds [19]. However, further research is needed to investigate the 
use of honey as wound dressings to manage malodor, exudates, pain, 
and bleeding, particularly in breast cancer wounds. As various types 
of honey available in Indonesia may have different properties with the 
other clinically tested honeys (e.g., MedihoneyTM [29,33,34]), it would 
be beneficial to study Indonesian’s native honeys’ properties that may 
have potentials to be utilized in breast cancer wound management. In 
addition, safety measures should also be incorporated in the utilization 
of new evidence for practice.
CONCLUSION
The use of honey for managing malignant wounds could be a favorable 
practice innovation concerning the health-care cost containment issues 
and limited resources. Nevertheless, extended research is needed to 
investigate the use of honey for treating pain and bleeding in malignant 
wounds so that the value of honey in this particular condition can be 
strengthened.
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